BIOLINERX

Live / Allowed — Publication / registration review complete (as of 18 Nov 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 May 2023 filing date already counts against anyone who files later.

Record

Serial number
76760226
Mark type
Word mark
Kind
Service mark
Register
Principal
Basis
Use in commerce (§1(a))
Filed
23 May 2023
Published for opposition
08 Dec 2026
Examining attorney
Brandon Lozeau
Attorney of record
Jeffrey H. Handelsman

Goods and services

  • Class 042 — Scientific and technological services: Pharmaceutical product development services, namely, pharmaceutical product development through the discovery of compounds that helps for the treatment of a variety of diseases and symptoms; pharmaceutical product development services for a wide variety of diseases and symptoms, namely, neuropathic pain, bacterial infections, solid cancerous tumors; pharmaceutical product development services of new compounds for use in medicines for oncology patients; pharmaceutical research services; research and development services in the field of biotechnology

Owner

Prosecution history

  • 08 Nov 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 28 Aug 2026 — ASSIGNED TO EXAMINER
  • 20 May 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 19 May 2026 — REQUEST FOR TRANSFORMATION PROCESSED - TOTAL

View this trademark record on Rightsy